JP2011523697A5 - - Google Patents

Download PDF

Info

Publication number
JP2011523697A5
JP2011523697A5 JP2011507650A JP2011507650A JP2011523697A5 JP 2011523697 A5 JP2011523697 A5 JP 2011523697A5 JP 2011507650 A JP2011507650 A JP 2011507650A JP 2011507650 A JP2011507650 A JP 2011507650A JP 2011523697 A5 JP2011523697 A5 JP 2011523697A5
Authority
JP
Japan
Prior art keywords
metal
lys
hsg
nota
neta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011507650A
Other languages
English (en)
Japanese (ja)
Other versions
JP5608914B2 (ja
JP2011523697A (ja
Filing date
Publication date
Priority claimed from US12/112,289 external-priority patent/US7563433B2/en
Priority claimed from US12/343,655 external-priority patent/US7993626B2/en
Application filed filed Critical
Publication of JP2011523697A publication Critical patent/JP2011523697A/ja
Publication of JP2011523697A5 publication Critical patent/JP2011523697A5/ja
Application granted granted Critical
Publication of JP5608914B2 publication Critical patent/JP5608914B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011507650A 2008-04-30 2009-04-30 タンパク質、ペプチドおよびその他の分子のf−18標識化のための改良型方法および組成物 Active JP5608914B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12/112,289 2008-04-30
US12/112,289 US7563433B2 (en) 2007-01-11 2008-04-30 Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US12/343,655 2008-12-24
US12/343,655 US7993626B2 (en) 2007-01-11 2008-12-24 Methods and compositions for F-18 labeling of proteins, peptides and other molecules
PCT/US2009/042333 WO2009135015A2 (en) 2008-04-30 2009-04-30 Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules

Publications (3)

Publication Number Publication Date
JP2011523697A JP2011523697A (ja) 2011-08-18
JP2011523697A5 true JP2011523697A5 (cg-RX-API-DMAC10.html) 2012-05-31
JP5608914B2 JP5608914B2 (ja) 2014-10-22

Family

ID=41255806

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011507650A Active JP5608914B2 (ja) 2008-04-30 2009-04-30 タンパク質、ペプチドおよびその他の分子のf−18標識化のための改良型方法および組成物

Country Status (7)

Country Link
US (2) US7993626B2 (cg-RX-API-DMAC10.html)
EP (1) EP2291678A4 (cg-RX-API-DMAC10.html)
JP (1) JP5608914B2 (cg-RX-API-DMAC10.html)
CN (1) CN102066974B (cg-RX-API-DMAC10.html)
AU (1) AU2009242641B2 (cg-RX-API-DMAC10.html)
CA (1) CA2720935C (cg-RX-API-DMAC10.html)
WO (1) WO2009135015A2 (cg-RX-API-DMAC10.html)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
US7993626B2 (en) * 2007-01-11 2011-08-09 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US7563433B2 (en) * 2007-01-11 2009-07-21 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US8545809B2 (en) * 2007-01-11 2013-10-01 Immunomedics, Inc. Methods and compositions for improved 18F labeling of proteins, peptides and other molecules
US20160045626A1 (en) * 2007-01-11 2016-02-18 Immunomedics, Inc. Methods and Compositions for Improved Labeling of Targeting Peptides
US8709382B2 (en) * 2007-01-11 2014-04-29 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
US8398956B2 (en) * 2007-01-11 2013-03-19 Immunomedics, Inc. In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
US8889100B2 (en) * 2007-01-11 2014-11-18 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
US9446995B2 (en) 2012-05-21 2016-09-20 Illinois Institute Of Technology Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
US10189803B2 (en) 2008-02-22 2019-01-29 Illinois Institute Of Technology Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
WO2010011367A2 (en) * 2008-02-22 2010-01-28 Illinois Institute Of Technology Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
US10556873B2 (en) 2008-02-22 2020-02-11 Illinois Institute Of Technology Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
US20120165650A1 (en) 2010-12-22 2012-06-28 General Electric Company Her2 binders
IN2012DN03177A (cg-RX-API-DMAC10.html) * 2009-12-04 2015-09-25 Immunomedics Inc
CA2814962A1 (en) * 2010-12-02 2012-06-07 Immunomedics, Inc. In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
EP2654803B1 (en) * 2010-12-22 2021-08-18 General Electric Company Radiolabeled her2-binding peptide conjugates
KR101142153B1 (ko) 2011-02-01 2012-05-10 서울대학교산학협력단 개선된 플루오르-18 표지를 위한 트리아자노난 유도체 또는 이의 약학적으로 허용가능한 염
EP2675485A4 (en) * 2011-02-15 2014-10-15 Immunomedics Inc ANTI-MUCIN ANTIBODY FOR THE EARLY RECOGNITION AND TREATMENT OF PANCREATIC CANCER
CN102295685B (zh) * 2011-07-03 2013-07-10 江苏省原子医学研究所 一种18f标记的prgd2化合物、其药盒、药盒制备方法及应用
JP6446268B2 (ja) * 2011-12-21 2018-12-26 ジーイー・ヘルスケア・リミテッド クエン酸緩衝液中の18f−フルシクロビン組成物
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201201062D0 (en) * 2012-01-23 2012-03-07 Ge Healthcare Ltd Radiofluorination method
JP6391095B2 (ja) * 2012-11-30 2018-09-19 国立大学法人京都大学 ポリペプチド及びイメージング方法
CN103030689B (zh) * 2012-12-27 2014-09-24 无锡米度生物技术有限公司 一种cart多肽化合物及其制备方法和应用
KR20150131208A (ko) 2013-03-13 2015-11-24 이미지냅 인코포레이티드 Cd8에의 항원 결합 구조체들
WO2015051362A1 (en) 2013-10-04 2015-04-09 Illinois Institute Of Technology Multifunctional chelators, complexes, and compositions thereof, and methods of using same
US20150217006A1 (en) * 2014-02-06 2015-08-06 Immunomedics, Inc. Al-f-18-labeled, al-f-19-labeled and ga-68-labeled gastrin-releasing peptide receptor (grpr)-antagonists for imaging of prostate cancer
WO2016065435A2 (en) * 2014-10-30 2016-05-06 Katholieke Universiteit Leuven Methods for low temperature fluorine-18 radiolabeling of biomolecules
US11596652B2 (en) 2015-02-18 2023-03-07 Enlivex Therapeutics R&D Ltd Early apoptotic cells for use in treating sepsis
US11497767B2 (en) 2015-02-18 2022-11-15 Enlivex Therapeutics R&D Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11304976B2 (en) 2015-02-18 2022-04-19 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11318163B2 (en) 2015-02-18 2022-05-03 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11000548B2 (en) 2015-02-18 2021-05-11 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11512289B2 (en) 2015-02-18 2022-11-29 Enlivex Therapeutics Rdo Ltd Combination immune therapy and cytokine control therapy for cancer treatment
JP6803339B2 (ja) 2015-04-21 2020-12-23 エンリヴェックス セラピューティクス リミテッド 治療用のプールされた血液アポトーシス細胞調製物及びそれらの使用
CN105277715A (zh) * 2015-05-28 2016-01-27 广州凯拓生物科技开发有限公司 巨噬细胞迁移抑制因子(mif)作为早期阿尔茨海默病血清分子标志物
CN108136012B (zh) 2015-08-07 2022-10-04 伊麦吉纳博公司 靶向分子的抗原结合构建体
JP6884155B2 (ja) 2016-02-18 2021-06-09 エンリヴェックス セラピューティクス リミテッド 癌治療のための併用免疫療法及びサイトカイン制御療法
CN108699108B (zh) * 2016-03-01 2022-04-08 国立大学法人千叶大学 放射性标记药物
CN109416359A (zh) * 2016-05-02 2019-03-01 匹兹堡大学联邦系统高等教育 用于分子成像和/或放射免疫疗法的二聚策略和化合物
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
TWI651097B (zh) * 2016-10-19 2019-02-21 行政院原子能委員會核能研究所 造影劑前驅物之製備方法
CN107353323B (zh) * 2016-12-26 2021-04-27 南京江原安迪科正电子研究发展有限公司 Al18F标记的PSMA靶向抑制剂及其制备方法与应用
WO2018147960A1 (en) 2017-02-08 2018-08-16 Imaginab, Inc. Extension sequences for diabodies
TW202005667A (zh) * 2018-04-05 2020-02-01 美商塔維達治療公司 Hsp90-靶向共軛體及其調合物
CA3118223A1 (en) * 2018-12-18 2020-06-25 Provincial Health Services Authority Dual mode 18f-labelled theranostic compounds and uses thereof
US11396535B2 (en) 2019-03-01 2022-07-26 Provincial Health Services Authority Cyclic peptide analogs of melanocortin and amanitin and methods of making such
CA3136979A1 (en) 2019-04-17 2020-10-22 Provincial Health Services Authority Radiolabelled compounds for diagnosis or treatment of prostate-spe cific membrane antigen-expressing cancer
JP2022533145A (ja) * 2019-05-13 2022-07-21 シャンハイ ポラリス バイオロジー カンパニー, リミテッド 生体分子を標識するためのタグ
WO2022082312A1 (en) 2020-10-21 2022-04-28 Provincial Health Services Authority Novel cxcr4-targeting compounds
CN113651662B (zh) * 2020-12-31 2023-10-27 复旦大学附属华山医院 一种靶向fgfr的新型肿瘤pet分子探针及其制备方法
CN115433138A (zh) * 2022-10-24 2022-12-06 苏州思萃同位素技术研究所有限公司 一种氘代配体及其制备方法
CN117919452B (zh) * 2023-03-09 2026-05-12 中国科学院宁波材料技术与工程研究所 一种亚细胞器主动靶向成像探针及其制备方法
WO2026046340A1 (zh) * 2024-08-30 2026-03-05 江苏恒瑞医药股份有限公司 一种f-18标记反应前体分子的方法
CN119661643A (zh) * 2024-12-17 2025-03-21 北京肿瘤医院(北京大学肿瘤医院) 一种cd25靶向环状多肽、分子探针及应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1222691A (en) * 1981-12-29 1987-06-09 Wilhelmus T. Goedemans Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments
FR2604092B1 (fr) 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
US5446147A (en) 1992-04-03 1995-08-29 Trustees Of The University Of Pennsylvania Fluorinated and iodinated dopamine agents
DE69837095T2 (de) 1997-09-03 2007-11-22 Immunomedics, Inc. Fluorierung von proteinen und peptiden für positronemissionstomographie
US7138103B2 (en) 1998-06-22 2006-11-21 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
US7387772B1 (en) 1999-06-22 2008-06-17 Immunimedics, Inc. Chimeric, human and humanized anti-CSAP monoclonal antibodies
US6962702B2 (en) * 1998-06-22 2005-11-08 Immunomedics Inc. Production and use of novel peptide-based agents for use with bi-specific antibodies
US6056939A (en) 1998-08-28 2000-05-02 Desreux; Jean F. Self-assembling heteropolymetallic chelates as imaging agents and radiopharmaceuticals
DE19846148C2 (de) 1998-10-01 2002-10-10 Igor Popov Verfahren zur Beurteilung der oxidativen Modifikation proteinhaltiger Stoffe mittels Messung ihrer antiradikalen Aktivität
US6207858B1 (en) 1999-03-03 2001-03-27 Idec Pharmaceuticals Corporation Regioselective synthesis of DTPA derivatives
AU785505B2 (en) 1999-10-15 2009-02-26 Mayo Foundation For Medical Education And Research Cobalamin conjugates useful as imaging and therapeutic agents
AU2001245401A1 (en) 2000-03-01 2001-09-12 Sumitomo Pharmaceuticals Company, Limited Hydrazones and analogs as cholesterol lowering agents
US7011816B2 (en) 2001-12-26 2006-03-14 Immunomedics, Inc. Labeling targeting agents with gallium-68 and gallium-67
CA2478047C (en) * 2002-03-01 2014-01-21 Immunomedics, Inc. Rs7 antibodies
US7081452B2 (en) 2002-06-03 2006-07-25 The United States Of America As Represented By The Department Of Health And Human Services Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
US7563433B2 (en) * 2007-01-11 2009-07-21 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US7597876B2 (en) 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
US7993626B2 (en) * 2007-01-11 2011-08-09 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
FR2841558B1 (fr) * 2002-07-01 2004-08-13 Commissariat Energie Atomique Peptides marques ayant une affinite pour un phospholipide et utilisations
EP1660519B1 (en) 2003-07-29 2014-05-14 Immunomedics, Inc. Conjugates comprising 2-[18F]fluoro-2-deoxy-D-glucose and a peptide molecule
WO2005077967A1 (en) * 2004-02-13 2005-08-25 The University Of British Columbia Radiolabeled compounds and compositions, their precursors and methods for their production
DE102004034517A1 (de) 2004-07-16 2006-02-16 Covion Organic Semiconductors Gmbh Metallkomplexe
WO2006017619A2 (en) * 2004-08-06 2006-02-16 The Regents Of The University Of California Receptor-binding cyclic peptides and methods of use
CA2604032C (en) * 2005-04-06 2017-08-22 Ibc Pharmaceuticals, Inc. Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
JP2009508090A (ja) * 2005-08-31 2009-02-26 イムノメディクス, インコーポレイテッド 予め標的化されたポジトロン放出断層撮影画像化のためのf−18ペプチド
EP1884515A1 (en) * 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
US7666392B2 (en) * 2006-09-15 2010-02-23 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
CN101568352B (zh) 2007-01-11 2013-08-21 免疫医学股份有限公司 用于蛋白质、肽和其他分子的改进的f-18标记的方法和组合物
CN101842833B (zh) * 2007-09-11 2012-07-18 沃伊斯亚吉公司 语音和音频编码中快速代数码本搜索的方法和设备

Similar Documents

Publication Publication Date Title
JP2016513098A5 (cg-RX-API-DMAC10.html)
JP2013503184A5 (cg-RX-API-DMAC10.html)
HRP20230487T1 (hr) Imunokonjugati s unutarstaničnom vezom koja se može rascijepiti
JP7483857B2 (ja) インターロイキン-2作用物質およびその使用
JP7499498B2 (ja) 細胞の細胞質への分子の送達のための構築物
CN1604966A (zh) 直接靶定的结合蛋白
JP6746845B2 (ja) 循環trop−2陽性癌細胞の単離、検出、診断及び/または特徴付け
JP5335651B2 (ja) インターナライジング抗cd74抗体およびその使用方法
US8383081B2 (en) Anti-CD74 immunoconjugates and methods of use
AU2022206577A1 (en) Heterotandem bicyclic peptide complexes
CN118894936A (zh) 抗cd3结合结构域和包含它们的抗体以及它们的产生及使用方法
JP2014514345A5 (cg-RX-API-DMAC10.html)
JP2022511813A5 (cg-RX-API-DMAC10.html)
JP2022028830A (ja) 長期作用型多重特異性分子および関連した方法
KR20230052881A (ko) 접합 부위를 갖는 t-세포 조절 폴리펩티드 및 이의 사용 방법
EP1798240B1 (en) Recombinant triplex scaffold-based polypeptides
CN1662557A (zh) 抗cd20抗体及其融合蛋白和使用方法
CN1675245A (zh) 人源化单克隆抗体hPAM4
JP2017019765A (ja) 改良された抗cd19抗体
JP2011505792A5 (cg-RX-API-DMAC10.html)
US20070048217A1 (en) F-18 peptides for pre targeted positron emission tomography imaging
Wu et al. ImmunoPET: harnessing antibodies for imaging immune cells
JP2009533021A5 (cg-RX-API-DMAC10.html)
JP2024502708A (ja) インターロイキン-2作用物質を使用する方法
CN121100133A (zh) 靶向cd3的抗体及其用途